Erythromycin Estolate [erythromycin estolát]
- Terms
-
Eromycin
Erythromycin Propionate Dodecyl Sulfate
Erythromycin Propionate Lauryl Sulfate
Erythromycin Propionate Monododecyl Sulfate
Ilosone
Lauromicina
A macrolide antibiotic, produced by Streptomyces erythreus. It is the lauryl sulfate salt of the propionic ester of erythromycin. This erythromycin salt acts primarily as a bacteriostatic agent. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.
- DUI
- D004918 MeSH Browser
- CUI
- M0007723
- CAS
- Erythromycin, 2'-propanoate, dodecyl sulfate (salt)
- Previous indexing
- Propionates (1974); Erythromycin (1970-1974); Sodium Dodecyl Sulfate (1974)
- History note
- 91(75); was see under ERYTHROMYCIN 1975-90
- Public note
- 91; was see under ERYTHROMYCIN 1975-90
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity 1
- UR
- urine